Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWorthington Grp Regulatory News (WRN)

  • This share is currently suspended. It was suspended at a price of 88.00

Share Price Information for Worthington Grp (WRN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 88.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 88.00
WRN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Capital Structure, Warrants and Loan Stock

31 Mar 2015 15:30

RNS Number : 0386J
Worthington Group PLC
31 March 2015
 



Worthington Group plc ("the Company" or "Worthington")

31st March 2015

FOR IMMEDIATE RELEASE

Reduction in Warrants and improvement in terms of Warrants and Convertible Loan Stock

Shareholders will recall from the Company's interim and final accounts, published on 29th August 2014, that the Company's share capital on a fully diluted basis, assuming shareholders agreed to conversion of loan notes and exercise of warrants at 5p, was as follows:

Ordinary shares 14,498,783

Warrants 35,090,378

Options 3,935,671

Unsecured Convertible Loan Notes ("UCLNs") £1,000,000 originally convertible into 20,000,000 ordinary shares at 5p per share subject to shareholders approval.

Secured Convertible Loan Notes ("SCLNs") of £461,393.10 originally convertible into 9,227,862 ordinary shares at 5p per share subject to shareholders approval.

The number of shares in issue on a fully diluted basis, assuming conversion and exercise of all loan stock, warrants and options would therefore have been: 82,752,694

At the time that these warrants, options and loan stock were issued the strike prices were at a premium to the then prevailing share price, and at a time when the Company was in a precarious financial position.

In recognition of the much enhanced prospects for the Company, and following negotiations with the holders of the Warrants and Loan Stock, the Company is pleased to announce the following improved terms:

At the time of the interim accounts, the 20m warrants issued in relation to the Law Financial transaction had already been reduced to 13,090,378 and can now only be exercised at 10p not 5p. Furthermore, if legal proceedings with an aggregate claim value exceeding £10m have not been commenced by the Claimants, pursuant to the Law Financial transaction, by 28th September 2015, or a settlement of £10m has not been agreed, then half of the loan notes (£500,000) and all of the 13,090,378 warrants issued in relation to the Law Financial transaction will be cancelled. If such proceedings are commenced, or settlement has been agreed, then 3,098,378 of the 13,090,378 warrants may only be exercised six months after any successful re-listing or takeover of the Company, and the remaining 10m warrants may not be exercised until 1st January 2017 unless the share price of Worthington exceeds £6 per share. If the Worthington share price does, at any time prior to 1st January 2017, exceed £6 per share, then the number of warrants that can be exercised will reduce from 10m to 3m which, once the share price exceeds £6, can then be exercised with the balance of 7m being cancelled.

The 8m warrants issued to European and Asian Ltd ("E&A"), and the 2m warrants issued to Mr Richard Spurway ("RJS"), can now only be exercised at 10p not 5p. Furthermore, E&A may only exercise 2,480,000 of its warrants, and RJS may only exercise 620,000 of his warrants six months after any successful re-listing or takeover of the Company. E&A's remaining 5,520,000 warrants, and RJS's remaining 1,380,000 warrants may not be exercised until 1st January 2017 unless the share price of Worthington exceeds £6 per share. If the Worthington share price does, at any time prior to 1st January 2017, exceed £6 per share then the number of E&A's warrants remaining that can be exercised will reduce from 5,520,000 to 2,320,000, and the number of RJS's warrants remaining that can be exercised will reduce from 1,380,000 to 580,000. Once the share price exceeds £6, then these remaining 2,900,000 warrants may then be exercised, with the balance of 4m being cancelled.

 

It is expected that, once the Company has completed the acquisition of its key takeover targets, improved terms relating to the conversion of secured loan notes and the exercise of related warrants will also be achieved.

The aggregate impact of the above changes is expected to further enhance the NAV per share envisaged by the Company's announcement on the 9th January 2015.

The interests held by Olympus Trading Group Ltd are held on behalf of more than 300 separate beneficiaries, none of whom would, on exercise or conversion, hold 3% or more of the Company's issued capital.

Further to the Company's announcements dated 1st September and 2nd October 2014 in relation to the issue & conversion of loan notes, and following the exercise of the options referred to above and the conversion of additional loan notes to fund corporate activity, the Company now has 25,016,509 ordinary shares in issue. The fully diluted position as at 30th March is therefore as follows:

 

Agreed changes to Worthington Group Plc Capital Structure as at 30th March 2015

Fully diluted as at 30th March 2015

Assuming no legal case and exceeds £6 per share

Assuming Legal

Case and exceeds £6 per share

Assuming Legal case and less than £6 per share

Assuming no legal case and less than £6 per share

Fully diluted as at 29th August 2014

Shares in issue

25,016,509

25,016,509

25,016,509

25,016,509

25,016,509

14,498,783

Warrants Olympus re Law Financial 20m reduced to

13,090,378

0

6,098,378

13,090,378

0

13,090,378

Warrants Olympus re £125,000 placing & £475,000 SCLNs

1,737,500

1,737,500

1,737,500

1,737,500

1,737,500

1,737,500

Warrants Renatus re £125,000 placing &£475,000 SCLNs

6,998,500

6,998,500

6,998,500

6,998,500

6,998,500

6,998,500

Warrants European & Asian re £475,000 SCLNs

3,024,000

3,024,000

3,024,000

3,024,000

3,024,000

3,024,000

Warrants European & Asian

8,000,000

4,800,000

4,800,000

8,000,000

8,000,000

8,000,000

Warrants Richard Spurway re £475,000 SCLNs

240,000

240,000

240,000

240,000

240,000

240,000

Warrants Richard Spurway

2,000,000

1,200,000

1,200,000

2,000,000

2,000,000

2,000,000

Options

0

0

0

0

0

3,935,671

 £1m UCLNs (re Law Financial) Olympus

5,944,405

944,405

5,944,405

5,944,405

944,405

20,000,000

£475,000 SCLNs , Renatus, Olympus, European & Asian and Richard Spurway

4,613,931

4,613,931

4,613,931

4,613,931

4,613,931

9,227,862

Total

70,665,223

48,574,845

59,673,223

70,665,223

52,574,845

82,752,694

 

It has been agreed between the Company, warrant holders and unsecured loan stock holders that no conversion of unsecured loan stock, or exercise of warrants, that would take the shares in issue above the authorised share capital of the Company (currently 52,736,850), will take place until approval for an increase in the authorised share capital of the Company has been obtained at a General meeting of shareholders of the Company.

Commenting on the amendments to the terms of the loan stock and warrants Doug Ware, CEO of Worthington said, "I am pleased that, as a consequence of the progress that the Company has made, we have been able to secure these improved terms for the Company".

About Worthington Group Plc ("Worthington")

 

Worthington (Stock Exchange LSE: WRN) is a British investment company that celebrates its 61st anniversary as a London Stock Exchange main market listed company this year. The Company has four areas of investment focus: property, litigation claims, new economy and emerging markets. The Company believes that exceptional shareholder returns can be achieved by utilising its main market Sterling paper to acquire investments in these sectors worldwide.

 

Note: Forward-looking statements contained in this announcement, including Worthington's strategy and plans, as well as expectations for future revenue and earnings, reflect Worthington's current views and assumptions with respect to future events and are subject to certain risks, uncertainties and assumptions. There are many factors that may cause actual results achieved to differ materially from expectations for future results and expectations that may be expressed in or form an assumption of such forward-looking statements. Such factors include risks related to the day to day business of Worthington, client volatility, sales fluctuations, the general economic climate, political and environment and other risks, cancellations, software failures and interruption to service to customers due to technical problems, acquisition delays and failure as well as other uncertainties related to the results of Worthington including risks of delays or closure of projects, price falls, currency fluctuations and changes in contract terms, legislation and administrative practices, as well as competition risk and other unforeseen factors. If one or more of such risks or factors of uncertainty were to materialise, or should one or more of the statements provided prove to be incorrect, actual developments may differ materially from the forward-looking statements contained in this announcement.

 

 

Enquiries:

 Charlotte Parham, Media information Tel: +44 203 291 1872

or email: media@worthingtongroupplc.com

PD Cosec - Company Secretary Tel: +44 208 940 0963

Website: www.worthingtongroupplc.com

Statement ends.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEALDFDAPSEFF
Date   Source Headline
7th Mar 20115:34 pmRNSCircular and Notice of General Meeting
9th Feb 201112:59 pmRNSInterim Management Statement
29th Oct 20107:00 amRNSInterim Results
7th Oct 20104:10 pmRNSDirectorate Change
1st Sep 201012:18 pmRNSDirectorate Change
12th Aug 201012:13 pmRNSHolding(s) in Company
12th Aug 201012:11 pmRNSHolding(s) in Company
10th Aug 20105:57 pmRNSHolding(s) in Company
28th Jul 20104:54 pmRNSHolding(s) in Company
22nd Jul 20104:54 pmRNSResult of AGM and Change of Registered Office
22nd Jul 201011:19 amRNSAGM & Interim Management Statement
16th Jul 20108:46 amRNSHolding(s) in Company
15th Jul 20104:47 pmRNSDirector's Dealing
6th Jul 20107:00 amRNSDirectorate Changes
21st Jun 20103:59 pmRNSAnnual Information Update/Posting of Annual Report
21st Jun 20108:26 amRNSHolding(s) in Company
16th Jun 201012:49 pmRNSResults for the Year Ended 31 March 2010
26th Feb 20109:35 amRNSPrice Movement
25th Feb 20104:03 pmRNSHolding(s) in Company
25th Feb 20108:59 amRNSHolding(s) in Company
24th Feb 20108:51 amRNSHolding(s) in Company
24th Feb 20108:48 amRNSHolding(s) in Company
10th Feb 201010:41 amRNSInterim Management Statement
18th Nov 200912:27 pmRNSInterim Report
4th Sep 200911:46 amRNSResult of AGM
4th Sep 200910:00 amRNSAGM & Interim Management Statement
1st Jul 20098:25 amRNSAnnual Information Update/Posting of Annual Report
18th Jun 20094:40 pmRNSPreliminary Results
5th Feb 20092:25 pmRNSInterim Management Statement
18th Nov 20088:06 amRNSInterim Results
15th Oct 20081:37 pmRNSHolding(s) in Company
15th Oct 20081:34 pmRNSHolding(s) in Company
1st Aug 20083:33 pmRNSResult of AGM
1st Aug 200810:03 amRNSAGM & Interim Management Stat
7th Jul 20089:18 amRNSAnnual Information Update
23rd Jun 200812:54 pmRNSFinal Preliminary Results
6th Feb 200812:04 pmRNSInterim Management Statement
16th Nov 20075:03 pmRNSDirector/PDMR Shareholding
9th Nov 20075:44 pmRNSFurther re Interim Results
8th Nov 200710:34 amRNSInterim Results
7th Sep 20074:40 pmRNSDirector Shareholding
31st Aug 20073:38 pmRNSAGM Statement
17th Aug 200712:07 pmRNSInterim Management Statement
30th Jul 200711:34 amRNSAnnual Information Update
13th Jul 20072:03 pmRNSPreliminary Results
29th May 20079:55 amRNSHolding(s) in Company
25th Jan 200710:33 amRNSProperty Disposal
18th Dec 20061:31 pmRNSTotal Voting Rights
30th Nov 20069:59 amRNSDirector/PDMR Shareholding
29th Nov 200611:41 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.